Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet; September 2023, Vol. 402 Issue: 10404 p798-808, 11p
- Subject
- Language
- ISSN
- 01406736; 1474547X